This aligns with previous studies showing that while levels of both BACE1 and Aβ34 are approximately doubled in AD brain tissue, deleting one BACE1 gene copy in mice reduces Aβ34 levels by half, proving a correlation between BACE1 protein levels and its amyloidolytic activity [8]. This evidence concerns the gene BACE1 and Alzheimer disease.